<DOC>
	<DOCNO>NCT02176993</DOCNO>
	<brief_summary>The investigator goal improve outcome patient acute stroke induce mild cerebral hypothermia surface cool cervical shoulder region use EMCOOLS Brain.Pads® . For project , investigator build research group 's experience hypothermia animal model invasive cool stroke patient . The COOL program prospectively evaluate safety , feasibility , patient acceptance efficacy mild cerebral hypothermia use EMCOOLS Brain.Pads® large cohort patient present acute stroke Emergency Department Universitair Ziekenhuis Brussel . The application EMCOOLS Brain.Pads® compare routine clinical practice randomize control trial . If proven safe , feasible , well-tolerated efficacious inhospital setting , future use prehospital acute stroke care incorporate telemedicine support , part Prehospital Stroke Study Universitair ziekenhuis Brussel ( PreSSUB ) .</brief_summary>
	<brief_title>Effects Surface Cooling On Stroke Outcome triaL ( COOL )</brief_title>
	<detailed_description>Several study identify fever independent predictor poor outcome patient acute stroke . Experimental data clinical study indicate therapeutic hypothermia neuroprotective effect associate well clinical outcome , probably reduction infarct volume cerebral edema patient ischemic hemorrhagic stroke , respectively . It expect beneficiary effect hypothermia pronounce initiate early stroke onset , underlines rational technique ideally initiated prehospital phase acute stroke management . Therapeutic hypothermia obtain external endovascular cooling . Most method aim low body temperature &lt; 33°C therefore require patient sedation intubation . In contrast patient cardiac arrest , sedation intubation preferably avoid profound cool entire body desire required stroke patient . EMCOOLS pads® originally develop EMCOOLS Medical Cooling Systems AG ( Austria ) profound external cooling patient cardiac arrest . The novel EMCOOLS Brain.Pad® redesign mildly low brain temperature noninvasive surface cool cerebropetal artery cervical level . Pilot study healthy volunteer demonstrate decrease 0.5-1°C ( tympanic measurement ) safely obtain application EMCOOLS Brain.Pad® 60 90 minute . No relevant side effect observe small study , possible effect cerebrovascular blood flow evaluate . Early application mild therapeutic hypothermia acute stroke patient build research group 's experience hypothermia animal model stroke patient . The investigator propose prospective clinical trial compare current clinical practice induction mild hypothermia use EMCOOLS Brain.Pads® patient present acute stroke . If safety , feasibility , patient acceptance efficacy confirm inhospital setting , next step involve evaluation approach prehospital acute stroke care .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Hypothermia</mesh_term>
	<criteria>Older 18 year Acute stroke onset &lt; 24 hour Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Acute stroke</keyword>
	<keyword>Therapeutic Hypothermia</keyword>
</DOC>